Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
ARYA Atherosclerosis|February 18, 2021
Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trialHossein Babaahmadi-Rezaei, Alireza Kheirollah, Saeed Hesam, et al.
Journal of Biomedical Materials Research. Part A|June 28, 2022
Recent advances and challenges in graphene-based nanocomposite scaffolds for tissue engineering applicationZahra Niknam, Faezeh Hosseinzadeh, Forough Shams, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 10, 2023
Brain Homogenate of a Rat Model of Alzheimer's Disease Modifies the Secretome of 3D Cultured Periodontal Ligament Stem Cells: A Potential Neuroregenerative TherapyFariba Mohebichamkhorami, Zahra Niknam, Mona Khoramjouy, et al.
Molecular Biology Reports|May 6, 2025
MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer's disease: a reviewAmir Modarresi Chahardehi, Reza Arefnezhad, Alireza Pourbafrani, et al.
IBRO Neuroscience Reports|June 30, 2025
The emerging role of circulating tumor DNA in brain tumor researchAmir Modarresi Chahardehi, Niki Faraji, Nikoo Emtiazi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 27, 2021
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approachZahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi, et al.
Archives of Iranian Medicine|February 4, 2024
Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter StudyAbdorreza Naser Moghadasi, Fereshteh Ashtari, Seyed Mohammad Baghbanian, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 29, 2026
Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivityRoya Abolfazli, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.
Pageof 4